New imaging agent shows promise for non-invasive endometriosis diagnosis
Recent Imaging Agent Offers Hope for Earlier Endometriosis Diagnosis and Personalized Treatment A novel molecular imaging agent, 99mTc-maraciclatide, is showing significant promise in revolutionizing the diagnosis and management of endometriosis, a chronic and often debilitating condition affecting millions of women worldwide. Recent Phase 2 trial data, published in The Lancet Obstetrics and Gynaecology, suggests the … Read more